vegfr2
Vaccineexperimental
Kinase insert domain receptor also known as vascular endothelial growth factor receptor 2 (VEGFR-2) is a VEGF receptor. KDR is the human gene encoding it. KDR has also been designated as CD309. KDR is also known as Flk1. — Wikipedia
Clinical trial activity
10 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
9
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2008 (NCT00632333)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Breast Neoplasms · Phase 1/Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Colonic Neoplasms · Phase 1/Phase 2
- Colorectal Neoplasms · Phase 1/Phase 2
- Esophageal Neoplasms · Phase 1/Phase 2
- Macular Degeneration · Phase 1
- Neovascularization, Pathologic · Phase 1
- Pancreatic Neoplasms · Phase 1
- Rectal Neoplasms · Phase 1/Phase 2
- Stomach Neoplasms · Phase 1/Phase 2
Mechanism of action
- Vascular endothelial growth factor receptor 2Immunity, active
KDR immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaKinase insert domain receptor ↗
Also known as
- vegfr2
- vegfr2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04508725 | N/A | Dec 5, 2020 | National Institutes of Health (NIH), Stanford University |
| NCT00791570 | Phase 1 | Oct 1, 2008 | Osaka University, University of Tokyo |
| NCT00677326 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00677612 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00681252 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00681577 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00681421 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT00673777 | Phase 1/Phase 2 (Phase 2) | May 1, 2008 | University of Tokyo |
| NCT01266720 | Phase 1 | Apr 1, 2008 | Fukushima Medical University, University of Tokyo |
| NCT00632333 | Phase 1 | Feb 1, 2008 | Teikyo University, University of Tokyo |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Tokyo | Academic/Hospital | 9 | 6 | 2 | 2008 |
| Fukushima Medical University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2020 |
| Osaka University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Teikyo University | Academic/Hospital | 1 | 1 | 1 | 2008 |
6 organizations
Page 1 / 1